Open Access

Implementing an SGLT2i for HFrEF treatment in my practice.

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Session

About the speaker

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations

2 more presentations in this session

Introduction, recap and overview of evidence for SGLT2 inhibitors in HFrEF.

Speaker: Professor J. Butler (Jackson, US)


Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF

Speakers: Professor A. Coats, Professor J. Butler, Professor S. Anker

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk